Cfo/Coo & Co-Founder
CurrentRevBio is a clinical stage medical device company engaged in the development and commercialization of a novel biomaterial called Tetranite™, which acts as an adhesive for bones. Not only does the material provide immediate load-bearing strength, bonding bone to bone as well as bone to metal, but it also reabsorbs and is replaced with new bone during the natural process of bone healing and remodeling. The use of this unique material will reduce the duration and complexity of medical procedures, allow for more minimally invasive surgeries, and will improve patient outcomes by reducing recovery time and the overall cost of care.